Li Wen-Ting, Luo Dan, Huang Jia-Ning, Wang Lin-Lin, Zhang Feng-Guo, Xi Tao, Liao Jian-Min, Lu Yuan-Yuan
a Department of Marine Pharmacy , China Pharmaceutical University , Nanjing , Nanjing Shi , China.
Nat Prod Res. 2018 Mar;32(6):662-667. doi: 10.1080/14786419.2017.1335730. Epub 2017 Jun 12.
One new alkaloid, named as acremolin C (1), was isolated from static culture of Antarctic fungus, Aspergillus sydowii SP-1, in an investigation of the antimicrobial constituents of this Antarctic microorganism, and its structure was determined by spectroscopic methods. Additionally, four known compounds, cyclo-(L-Trp-L-Phe) (2), 4-hydroxyphenylacetic acid (3), (7S)-(+)-hydroxysydonic acid (4) and (7S, 11S)-(+)-12-hydroxysydonic acid (5), were isolated and identified. Biological studies disclosed that compounds 2, 4 and 5 showed moderate inhibitions against methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE) as comparing to tigecycline, while compound 1 displayed weak inhibition activities against MRSA and MRSE.
在对这种南极微生物的抗菌成分进行研究时,从南极真菌米曲霉SP - 1的静置培养物中分离出一种名为阿克里莫林C(1)的新生物碱,并通过光谱方法确定了其结构。此外,还分离并鉴定了四种已知化合物,环(L - 色氨酸 - L - 苯丙氨酸)(2)、4 - 羟基苯乙酸(3)、(7S) - (+) - 羟基辛酮酸(4)和(7S,11S) - (+) - 12 - 羟基辛酮酸(5)。生物学研究表明,与替加环素相比,化合物2、4和5对耐甲氧西林金黄色葡萄球菌(MRSA)和耐甲氧西林表皮葡萄球菌(MRSE)表现出中等程度的抑制作用,而化合物1对MRSA和MRSE表现出较弱的抑制活性。